International Journal of Clinical Pediatric Dentistry

Register      Login

VOLUME 11 , ISSUE 6 ( November-December, 2018 ) > List of Articles


Clinical and Radiographic Evaluations of Biodentine™ Pulpotomies in Mature Primary Molars (Stage 2)

Hitaf Nasrallah, Balsam El Noueiri, Charles Pilipili, Fouad Ayoub

Keywords : Biodentine, Complete root formation, Primary molars, Pulp canal obliteration, Pulpotomy

Citation Information : Nasrallah H, Noueiri BE, Pilipili C, Ayoub F. Clinical and Radiographic Evaluations of Biodentine™ Pulpotomies in Mature Primary Molars (Stage 2). Int J Clin Pediatr Dent 2018; 11 (6):496-504.

DOI: 10.5005/jp-journals-10005-1564

License: CC BY-NC 4.0

Published Online: 01-04-2012

Copyright Statement:  Copyright © 2018; The Author(s).


Introduction: The preservation of the integrity and health of primary teeth and their supporting tissues is of great importance in maintaining arch length space, mastication, speech, and esthetics. A pulpotomy is a common therapy performed on a primary tooth presenting reversible pulpitis or a traumatic pulp exposure, allowing its conservation on the arch until its loss. Aim: The study aims to clinically and radiographically evaluate the rates of success and efficacy of Biodentine™ as pulpotomy medicament exclusively on deciduous molars with complete roots formation (stage 2). Materials and methods: A total number of 75 primary molars in stage 2 of formation were selected to undergo pulpotomy treatment. All teeth were restored with a stainless-steel crown. The clinical success was evaluated at 1, 3, 6 and 12-month intervals. The radiographic follow-up evaluations were at 6 and 12 months. The resulting data were tabulated and statistically analyzed. Results: Among the 75 teeth treated with Biodentine™, one tooth revealed abnormal mobility and tenderness to percussion at the end of the 1st month. PLS widening and the bone lesion was not seen in any of the 74 remaining cases. Forty teeth (54.1%) showed pulp canal obliteration (PCO), and none of the cases developed a draining sinus or had increased mobility. At the end of the 1-year follow-up, the clinical and radiographic success rates were 98.7% and 100%, respectively. Conclusion: Pulpotomies performed with Biodentine™ on stage 2 primary molars were generally very satisfactory and fulfilled all requirements, covering all needs. This innovative bioactive medicament seems to be a “heroic” material. The excellent outcomes of the present study are indicative that Biodentine™ is a promising biomaterial to promote pulp repair after pulpotomy in clinical practice.

PDF Share
  1. Hugar SM, Deshpande SD. Comparative investigation of clinical/radiographical signs of mineral trioxide aggregate and formocresol on pulpotomized primary molars. Contemp Clin Dent 2010;1(3):146-151.
  2. Godhi B, Sood PB, Sharma A. Effects of mineral trioxide aggregate and formocresol on vital pulp after pulpotomy of primary molars: An in vivo study. Contemp Clin Dent 2011; 2(4):296-301.
  3. Cohn C. Pulpotomy for Primary Teeth with Tricalcium Silicate Material. Inside Dentistry. 2013; 9(9):100-102.
  4. Camp JH, Fuks AB. Pediatric endodontics: Endodontic treatment for the primary and young permanent dentition. In: Cohen S, Hargreaves KM, eds. Pathways of the pulp. 10th edition, Mosby Elsevier 2011:808-857.
  5. Guideline on Pulp Therapy for Primary and Immature Permanent Teeth. Pediatr Dent 2016;38(6):280-288.
  6. Neamatollahi H, Tajik A. Comparison of clinical and radiographic success rates of pulpotomy in primary molars using formocresol, ferric sulfate and mineral trioxide aggregate (MTA). J Dent Tehran Univ Med Sci 2006:7-14.
  7. Pilipili CM, Vanden Abbeele A, van den Abbeele K. La pulpotomie de la dent temporaire. Rev Belge Med Dent (1984) 2004;59(3):156-162.
  8. Demars C., Fortier JP. Propos sur l'endodontie des dents temporaires. Actual Odontostomatol (Paris) 1981;35(134): 213-224.
  9. Dean JA, Mack RB, Fulkerson BT, et al. Comparison of electrosurgical and formocresol pulpotomy procedures in children. Int J Paediatr Dent. 2002;12(3):177-182.
  10. Liu JF, Chen LR, Chao SY. Laser pulpotomy of primary teeth. Pediatr Dent 1999;21(2):128-129.
  11. Gupta G, Rana V, Srivastava N, et al. Laser Pulpotomy–An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Int J Clin Pediatr Dent 2015; 8(1):18-21.
  12. El Meligy OA, Allazzam S, Alamoudi NM. Comparison between biodentine and formocresol for pulpotomy of primary teeth: A randomized clinical trial. Quintessence Int. 2016;47(7):571-580.
  13. Lewis B. The obsolescence of formocresol. Br Dent J. 2009 12;207(11):525-528.
  14. Fuks AB, Bimstein E. Clinical evaluation of diluted formocresol pulpotomies in primary teeth of school children. Pediatr Dent 1981;3(4):321-324.
  15. Ghajari MF, Kermani MN, Kharazi Fard MJ, Vatanpour M. Comparison of Formocresol and Ferric Sulfate Pulpotomy in Primary Molars: A Systematic Review and Meta-analysis. Jdt 2009;6(1):29-36.
  16. Fuks AB, Bimstein E, Guelmann M, et al. Assessment of a 2 percent buffered glutaraldehyde solution in pulpotomized primary teeth of schoolchildren. ASDC J Dent Child 1990;57(5):371-375. 17 Havale R, Anegundi RT, Indushekar K, et al. Clinical and radiographic evaluation of pulpotomies in primary molars with formocresol, glutaraldehyde and ferric sulphate. Oral Health Dent Manag 2013;12(1):24-31.
  17. Ibricevic H, Al-Jame Q. Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow-up study. Eur J Paediatr Dent. 2003;4(1):28-32.
  18. Waterhouse PJ, Nunn JH, Whitworth JM. An investigation of the relative efficacy of Buckley's Formocresol and calcium hydroxide in primary molar vital pulp therapy. Br Dent J 2000;188(1): 32-36.
  19. Pimenta HC, Borges ÁH, Bandeca MC, et al. Antimicrobial activity of filling materials used in primary teeth pulpotomy. J Int Oral Health 2015;7(4):54-57.
  20. Collado-González M, García-Bernal D, Oñate-Sánchez RE, et al. Cytotoxicity and bioactivity of various pulpotomy materials on stem cells from human exfoliated primary teeth. Int Endod J 2017;50 Suppl 2:e19-e30.
  21. Simancas-Pallares MA, Diaz-Caballero AJ, Luna-Ricardo LM. Mineral trioxide aggregate in primary teeth pulpotomy. A systematic literature review. Med Oral Patol Oral Cir Bucal 2010;15(6):e942-e946.
  22. Maturo P, Costacurta M, Bartolino M, et al. MTA applications in pediatric dentistry. Oral Implantol (Rome) 2009;2(3): 37-44.
  23. Kabaktchieva R, Gateva N. Vital pulpotomy in primary teeth with mineral trioxide aggregate (MTA). Journal of IMAB - Annual Proceeding 2009:102-108.
  24. Kim JR, Nosrat A, Fouad AF. Interfacial characteristics of Biodentine and MTA with dentine in simulated body fluid. J Dent 2015;43(2):241-247.
  25. Asgary S, Ahmadyar M. Vital pulp therapy using calcium enriched mixture: An evidence-based review. J Conserv Dent. 2013;16(2):92-98.
  26. Conti TR, Sakai VT, Fornetti AP, et al. Pulpotomies with Portland cement in human primary molars. J Appl Oral Sci 2009;17(1):66-69.
  27. Bali P, Shivekshith AK, Allamaprabhu CR, et al. Calcium enriched mixture cement: A review. Int J Contemp Dent Med Rev (2014):1-3.
  28. Nosrat A, Asgary S, Eghbal MJ, et al. Calcium-enriched mixture cement as artificial apical barrier: A case series. J Conserv Dent 2011;14(4):427-431.
  29. Laurent P, Camps J, About I. Biodentine induces TGF-ƒÀ1 release from human pulp cells and early dental pulp mineralization. Int Endod J 2012;45(5):439-448.
  30. De Souza ET, Nunes Tameirao MD, Roter JM, et al. Tridimensional quantitative porosity characterization of three set calcium silicate-based repair cements for endodontic use. Microsc Res Tech 2013;76(10):1093-1098.
  31. Grech L, Mallia B, Camilleri J. Investigation of the physical properties of tricalcium silicate cement-based root-end filling materials. Dent Mater 2013;29(2):e20-e28.
  32. Sawyer AN1, Nikonov SY, Pancio AK, Niu LN, Agee KA, Loushine RJ, Weller RN, Pashley DH, Tay FR. Effects of calcium silicate-based materials on the flexural properties of dentin. J Endod. 2012;38(5):680-683.
  33. Villat C, Tran XV, Pradelle-Plasse N, et al. Impedance methodology: A new way to characterize the setting reaction of dental cements. Dent Mater. 2010;26(12):1127-1132.
  34. Tanalp J, Karap.nar-Kazanda. M, S, et al. Comparison of the radiopacities of different root-end filling and repair materials. Scientific World Journal. 2013;2013: 594-950.
  35. Raskin A, Eschrich G, Dejou J, et al. In vitro microleakage of Biodentine as a dentin substitute compared to Fuji II LC in cervical lining restorations. J Adhes Dent. 2012;14(6):535-542.
  36. Kayahan MB, Nekoofar MH, McCann A, et al. Effect of acid etching procedures on the compressive strength of 4 calcium silicate-based endodontic cements. J Endod 2013;39(12):1646- 1648.
  37. Odaba. ME, Bani M, Tirali RE. Shear bond strengths of different adhesive systems to biodentine. Scientific World Journal 2013;2013:626103.
  38. Madfa AA, Al-Sanabani FA, Al-Qudami Al-Kudami NH. Endodontic Repair Filling Materials: A Review Article. British Journal of Medicine & Medical Research; March 2014;4(16):3059-3079.
  39. Malkondu O, Karapinar Kazanda. M, E. A review on biodentine, a contemporary dentine replacement and repair material. Biomed Res Int Jun 2014;2014: 160951.
  40. Shayegan A1, Jurysta C, Atash R, et al. Biodentine used as a pulp-capping agent in primary pig teeth. Pediatr Dent 2012;34(7):e202-e208.
  41. Zanini M, Sautier JM, Berdal A, et al. Biodentine induces immortalized murine pulp cell differentiation into odontoblastlike cells and stimulates biomineralization. J Endod 2012;38:1220-1226.
  42. Rajasekharan S, Martens LC, Cauwels RG, et al. Biodentine. material characteristics and clinical applications: a review of the literature. Eur Arch Paediatr Dent 2014;15(3): 147-158.
  43. Camilleri J, Laurent P, About I. Hydration of Biodentine, Theracal LC, and a prototype tricalcium silicate-based dentin replacement material after pulp capping in entire tooth cultures. J Endod 2014;40(11):1846-1854.
  44. Nasseh H, El Noueiri B, Pilipili C, et al. Evaluation of biodentine pulpotomies in deciduous molars with physiological root resorption (stage 3). Int J Clin Pediatr Dent (accepted for publication).
  45. Ranly DM. Pulpotomy therapy in primary teeth: new modalities for old rationales. Pediatr Dent 1994;16(6): 403-409.
  46. Parisay I, Ghoddusi J, Forghani M. A review on vital pulp therapy in primary teeth. Iran Endod J 2015;10(1): 6-15.
  47. Peng L, Ye L, Guo X, et al. Evaluation of formocresol versus ferric sulphate primary molar pulpotomy: a systematic review and meta-analysis. Int Endod J 2007;40:751-757.
  48. Kusum B, Rakesh K, Richa K. Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restor Dent Endod 2015;40(4):276-285.
  49. Kabbinale P, Chethena KC, Kuttappa MA. Role of calcium enriched mixture in endodontics. Arch Med Health Sci 2015;3:80-84.
  50. Caicedo R, Abbott PV, Alongi DJ, et al. Clinical, radiographic and histological analysis of the effects of mineral trioxide aggregate used in direct pulp capping and pulpotomies of primary teeth. Aust Dent J 2006;51(4): 297-305.
  51. De Rossi A, Silva LA, Gaton-Hernandez P, et al. Comparison of pulpal responses to pulpotomy and pulp capping with biodentine and mineral trioxide aggregate in dogs. J Endod 2014;40(9):1362-1369.
  52. Camilleri J, Sorrentino F, Damidot D. Investigation of the hydration and bioactivity of radiopacified tricalcium silicate cement, Biodentine and MTA Angelus. Dent Mater 2013;29(5):580-593.
  53. Rajasekharan S, Martens LC, Vandenbulcke J, et al. Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. Int Endod J 2017;50(3): 215-228.
  54. Rodd HD, Waterhouse PJ, Fuks AB, et al. British Society of Paediatric Dentistry. Pulp therapy for primary molars. Int J Paediatr Dent. 2006;16(Suppl 1):15-23.
  55. Farrokh Gisoure E. Comparison of three pulpotomy agents in primary molars: a randomised clinical trial. Iran Endod J. 2011;6(1):11-14.
  56. Cuadros-Fernández C, Lorente Rodríguez AI, Sáez-Martínez S, et al. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial. Clin Oral Investig 2016;20(7): 1639-1645.
  57. Nowicka A, Lipski M, Parafiniuk M, et al. Response of human dental pulp capped with biodentine and mineral trioxide aggregate. J Endod 2013;39(6):743-77.
  58. Camilleri J. Investigation of Biodentine as dentine replacement material. J Dent 2013;41(7):600-610.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.